Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ADMD > SEC Filings for ADMD > Form 8-K on 15-Nov-2013All Recent SEC Filings




Other Events

Item 8.01 Other Events.

After concluding that: (i) the Company's employees and consultants had diligently continued working during a period in which the Company's cash constraints required that they reduce, waive or defer cash compensation; (ii) the Company's employees and consultants contributed to material milestones in the Company's progress to becoming a fully operating Company, including the Company's filing for pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGelTM brachytherapy cancer product; (iii) the efforts and achievements of the Company's employees and consultants were essential pre-requisites to the success of the Company's anticipated receipt of additional funding; (iv) the Company's stock price has begun to recover, closing at 12 cents per share; (v) the stock options previously granted to employees and consultants are materially out-of-the money and that is demoralizing to employees and consultants, particularly in light of their achievements; and (vi) subject to the receipt of financing, FDA clearance for its RadioGel products and other necessary prerequisites to success, the Company's stock price could continue to recover, but only with the continued efforts of its employees and consultants, the Board of Directors of AMIC has reduced the strike price of the options in the table below from a previous range of $.016 to $.30 to an exercise price of.15 per share, approximately a 25% premium to the stock's last price:

The change in exercise price does not extend the remaining term of the options.


                                                          Original exercise      Repriced exercise
 Number of Options      Date issued    Expiration date          price                  price

            965,000          1/12/2011        1/12/2014   $             0.30     $             0.15
            750,000          6/20/2012        6/20/2015   $             0.20     $             0.15
            250,000           9/5/2012         9/5/2015   $             0.21     $             0.15
            700,000         11/14/2012       11/14/2015   $             0.16     $             0.15
          1,785,000          2/11/2013        2/11/2016   $             0.19     $             0.15
          3,250,000          2/11/2013        2/11/2023   $             0.19     $             0.15


The total reduction in exercise price is $405,689.96.

The BOD granted these options to attract and maintain talented individuals working on behalf of the Company.

  Add ADMD to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ADMD - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.